Marin-Gomez Francesc X, Garcia-Moreno Marchán Rocio, Mayos-Fernandez Anabel, Flores-Mateo Gemma, Granado-Font Esther, Barrera Uriarte Maria Luisa, Duch Jordi, Rey-Reñones Cristina
Servei d'Atenció Primària d'Osona, Gerència Territorial de la Catalunya Central, Institut Català de la Salut, Vic, Spain.
Unitat de Suport a la Recerca Catalunya Central, Institut Universitari d'Investigació en Atenció Primària Jordi Gol, Sant Fruitós de Bages, Spain.
JMIR Serious Games. 2019 Mar 27;7(1):e12835. doi: 10.2196/12835.
Tobacco use during pregnancy entails a serious risk to the mother and harmful effects on the development of the child. Europe has the highest tobacco smoking prevalence (19.3%) compared with the 6.8% global mean. Between 20% to 30% of pregnant women used tobacco during pregnancy worldwide. These data emphasize the urgent need for community education and implementation of prevention strategies focused on the risks associated with tobacco use during pregnancy.
The aim of this study was to investigate the efficacy of an intervention that incorporates a serious game (Tobbstop) to help pregnant smokers quit smoking.
A two-arm randomized controlled trial enrolled 42 women who visited 2 primary care centers in Catalonia, Spain, between March 2015 and November 2016. All participants were pregnant smokers, above 18 years old, attending consultation with a midwife during the first trimester of pregnancy, and had expressed their desire to stop smoking. Participants were randomized to the intervention (n=21) or control group (n=21). The intervention group was instructed to install the game on their mobile phone or tablet and use it for 3 months. Until delivery, all the participants were assessed on their stage of smoking cessation during their follow-up midwife consultations. The primary outcome was continuous tobacco abstinence until delivery confirmed by the amount of carbon monoxide at each visit, measured with a carboxymeter.
Continuous abstinence until delivery outcome was 57% (12/21) in the intervention group versus 14% (3/21) in the control group (hazard ratio=4.31; 95% CI 1.87-9.97; P=.001). The mean of total days without smoking until delivery was higher in the intervention group (mean 139.75, SD 21.76) compared with the control group (mean 33.28, SD 13.27; P<.001). In addition, a Kapplan-Meier survival analysis showed that intervention group has a higher abstinence rate compared with the control group (log-rank test, χ=13.91; P<.001).
Serious game use is associated with an increased likelihood to maintain abstinence during the intervention period if compared with those not using the game. Pregnancy is an ideal opportunity to intervene and control tobacco use among future mothers. On the other hand, serious games are an emerging technology, growing in importance, which are shown to be a good tool to help quitting smoking during pregnancy and also to maintain this abstinent behavior. However, because of the study design limitations, these outcomes should be interpreted with caution. More research, using larger samples and longer follow-up periods, is needed to replicate the findings of this study.
ClinicalTrials.gov NCT01734421; https://clinicaltrials.gov/ct2/show/NCT01734421 (Archived by WebCite at http://www.webcitation.org/75ISc59pB).
孕期吸烟对母亲有严重风险,并对胎儿发育产生有害影响。欧洲的吸烟率最高(19.3%),而全球平均吸烟率为6.8%。全球范围内,20%至30%的孕妇在孕期吸烟。这些数据凸显了开展社区教育以及实施针对孕期吸烟相关风险的预防策略的迫切需求。
本研究旨在调查一种包含严肃游戏(Tobbstop)的干预措施帮助怀孕吸烟者戒烟的效果。
一项双臂随机对照试验纳入了42名女性,她们于2015年3月至2016年11月期间前往西班牙加泰罗尼亚的2家初级保健中心就诊。所有参与者均为怀孕吸烟者,年龄在18岁以上,在孕早期接受助产士咨询,且表示有戒烟意愿。参与者被随机分为干预组(n = 21)或对照组(n = 21)。干预组被要求在其手机或平板电脑上安装该游戏并使用3个月。直至分娩,所有参与者在后续的助产士咨询中接受戒烟阶段评估。主要结局是直至分娩时持续戒烟,通过每次就诊时用一氧化碳测定仪测量的一氧化碳量来确认。
干预组直至分娩时的持续戒烟率为57%(12/21),而对照组为14%(3/21)(风险比 = 4.31;95%置信区间1.87 - 9.97;P = 0.001)。干预组直至分娩时无吸烟的总天数均值(均值139.75,标准差21.76)高于对照组(均值33.28,标准差13.27;P < 0.001)。此外,Kapplan - Meier生存分析表明,干预组的戒烟率高于对照组(对数秩检验,χ = 13.91;P < 0.001)。
与不使用游戏者相比,使用严肃游戏在干预期间维持戒烟的可能性增加。怀孕是干预和控制未来母亲吸烟行为的理想时机。另一方面,严肃游戏是一种新兴技术,其重要性日益增加,已被证明是帮助孕期戒烟并维持这种戒烟行为的良好工具。然而,由于研究设计的局限性,这些结果应谨慎解读。需要更多使用更大样本和更长随访期的研究来复制本研究的结果。
ClinicalTrials.gov NCT01734421;https://clinicaltrials.gov/ct2/show/NCT01734421(由WebCite存档于http://www.webcitation.org/75ISc59pB)